No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine-a prospective multicenter study by the Polish Adult Leukemia Group.
Mądry K, Lis K, Sienkiewicz E, Drozd-Sokołowska J, Biecek P, Sośnia O, Gołos A, Olszewska-Szopa M, Obara A, Walkowiak Z, Ściesińska J, Subocz E, Butrym A, Machowicz R, Budziszewska K, Basak G.
Mądry K, et al. Among authors: obara a.
Front Oncol. 2024 Jun 13;14:1404322. doi: 10.3389/fonc.2024.1404322. eCollection 2024.
Front Oncol. 2024.
PMID: 38939343
Free PMC article.